Table 1 Dichotomous variables as number of subjects, n (%), with elevated vs non-elevated cTnT, with p-values from chi square tests.
From: Determinants of cardiac troponin T elevation in COPD exacerbation – a cross-sectional study
Characteristic | cTnT = 0.04 (n≥ 120) | cTnT < 0.04 (n = 321) | p-value |
|---|---|---|---|
Gender | |||
Female | 51 (43) | 166 (52) | 0.09 |
ECG | |||
Atrial fibrillation | 20 (17) | 34 (11) | 0.08 |
Chest radiograph | |||
Hyperinflation | 31 (26) | 99 (31) | 0.31 |
Infiltrate | 50 (43) | 77 (27) | 0.001 |
Cardiomegaly | 69 (58) | 111 (35) | < 0.001 |
Congestion (any sign) | 53 (44) | 94 (29) | 0.003 |
Medical history | |||
Myocardial infarction | 35 (33) | 58 (19) | 0.002 |
Heart failure | 31 (26) | 27 (8) | < 0.001 |
Diabetes | 29 (24) | 41 (13) | 0.004 |
Hypertension | 32 (27) | 75 (23) | 0.47 |
Thromboembolism | 4 (3) | 11 (3) | 0.96 |
Cancer | 17 (14) | 41 (13) | 0.7 |
Treatment | |||
LTOT | 9 (8) | 27 (9) | 0.86 |
Inhaled beta2-agonists | 91 (86) | 250 (88) | 0.62 |
Inhaled corticosteroids | 60 (55) | 202 (66) | 0.04 |
Warfarin | 16 (15) | 33 (11) | 0.30 |
Aspirin | 45 (38) | 93 (29) | 0.09 |
ACE inhibitors | 32 (29) | 63 (21) | 0.07 |
Beta-blockers | 18 (16) | 52 (17) | 0.88 |
Statins | 15 (13) | 55 (17) | 0.24 |